Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.

  title={Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.},
  author={Erik M. Volz and Swapnil Mishra and Meera Chand and Jeffrey C. Barrett and Robert Johnson and Lily Geidelberg and Wes Hinsley and Daniel J. Laydon and Gavin Dabrera and {\'A}ine Niamh O'toole and Roberto Amato and Manon Ragonnet-Cronin and Ian Harrison and Ben Jackson and Cristina V. Ariani and Olivia Boyd and Nicholas James Loman and John T. McCrone and S{\'o}nia Gonçalves and David Jorgensen and Richard Myers and Verity Hill and David K. Jackson and Katy A. M. Gaythorpe and Natalie Groves and John Sillitoe and Dominic P. Kwiatkowski and Seth Flaxman and Oliver Ratmann and Samir Bhatt and Susan Hopkins and Axel Gandy and Andrew Rambaut and Neil M. Ferguson},
The SARS-CoV-2 lineage B.1.1.7, designated a Variant of Concern 202012/01 (VOC) by Public Health England1, originated in the UK in late Summer to early Autumn 20202. Whole genome SARS-CoV-2 sequence data collected from community-based diagnostic testing shows an unprecedentedly rapid expansion of the B.1.1.7 lineage during Autumn 2020, suggesting a selective advantage. We find that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S-gene target… 

Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England

SARS-CoV-2 lineage dynamics in England from January to March 2021 inferred from representative community samples

Describing lineage dynamics and phylogenetic relationships using sequences obtained from a random community sample who provided a throat and nose swab for rt-PCR during the first three months of 2021 as part of the REal-time Assessment of Community Transmission-1 (REACT-1) study suggests sequence data from representative community surveys such as REact-1 can augment routine genomic surveillance.

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland

The dynamics of increase in frequency of SARS-CoV-2 variants is as expected based on the observations in the UK, and the rate of spread of all variants slowed down recently.

Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron

This model proposes a reliable Bayesian framework to predict the spread trends of VOCs based on early-stage data, and evaluates the effects of public health policies, which may help to better prepare for the upcoming Omicron variant, which is now spreading at an unprecedented speed.

A new SARS-CoV-2 lineage that shares mutations with known Variants of Concern is rejected by automated sequence repository quality control

A SARS-CoV-2 lineage that shares N501Y, P681H, and other mutations with known variants of concern is reported that is present in at least 20 states across the USA and in at at least six countries, suggesting that the frequency of this new lineage is underestimated using public data.

Mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants

This work provides a reliable method for quantifying novel variants' transmissibility under subsampling (as newly-reported Delta, B.1.2) and highlights the importance of continuous genomic surveillance.

The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021

To assess SARS-CoV-2 variants spread, variant-specific reverse-transcription-PCR tests performed on samples from 12 April–7 May 2021 in France found that variants of concern (VOC) β and/or γ had a significant transmission advantage over VOC α in Île- de-France and Hauts-de-France regions, consistent with VOC β’s immune evasion abilities.

Publisher Correction: Genomic reconstruction of the SARS CoV-2 epidemic in England

This analysis reveals a series of sub-epidemics that peaked in the early autumn of 2020, followed by a jump in transmissibility of the B. 1.1.7/Alpha lineage, which grew when other lineages declined during the second national lockdown and regionally tiered restrictions between November and December 2020.

The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK

The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organisation (WHO) as Alpha. Originating in early Autumn but discovered in

Genomic reconstruction of the SARS-CoV-2 epidemic across England from September 2020 to May 2021

Using the dense genomic surveillance generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 62 different lineages in each of 315 English local authorities between September 2020 and April 2021, this analysis reveals a series of sub-epidemics that peaked in the early autumn of 2020, followed by a singular jump in transmissibility of the B. 1.1.7 lineage in April 2021.



Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

Two new SARS-CoV-2 lineages with the N501Y mutation in the receptor-binding domain of the spike protein spread rapidly in the United Kingdom and were estimated to be more transmissible than the 501N lineage.

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

A mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia is developed, and a panel of adaptive mutations potentially associated with the increased virulence are revealed.

Viral Phylodynamics

Viral phylogenies can be used to investigate important epidemiological, immunological, and evolutionary processes, such as epidemic spread, spatio-temporal dynamics including metapopulation dynamics, zoonotic transmission, tissue tropism, and antigenic drift, and quantitative investigation of these processes through the consideration of viral phylogenies is the central aim of viral phylodynamics.

Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK

Large-scale virus genome sequencing reveals the genetic structure and importation dynamics of a national COVID-19 epidemic, which was one of world’s largest and was unusually well represented by virus genomic sampling.

Evolutionary analysis of the dynamics of viral infectious disease

This Review outlines the questions that can be answered using viral evolutionary analysis across a wide range of biological scales and describes the current state of the art in such analysis.